EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Mucoadhesive Drug Delivery Systems for Oral Chronic Inflammatory Mucosal Diseases. The Future is Already Present. A Systematic Review

M E Mauceri, M Coppini iD, V De Caro iD, G Di Prima iD, R Mauceri iD, V Panzarella, G Giuliana, G Campisi

Oral Diseases · 2026-01 · 32 (1) · 25-36

DOI: 10.1111/odi.70042 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Oral Diseases, online erschienen am 23.07.2025. Verfasst von M E Mauceri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche, Università degli Studi di Palermo, Palermo, Italy. Hauptthemen laut MEDLINE: Drug Delivery Systems, Stomatitis, Aphthous, Lichen Planus, Oral. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute Project GENESIS-ATI, cod. T3-AN-11, Ministero dell'Università e della Ricerca and European Union-Next Generation EU, cod. PNRR M4.C2.1.1-2022CLLMCP_002.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oral lichen planus (OLP) and recurrent aphthous stomatitis (RAS) are considered the most painful oral inflammatory diseases, with high global prevalence and significant impacts on patients' quality of life. In the last decades, researchers have been exploring mucoadhesive drug delivery systems (MDDS) to improve drugs safety and efficacy through optimized formulations for enhancing patients compliance while addressing the limitations of semisolid products.

Objective

To assess the clinical efficacy of different MDDS (e.g., tablets, films, and patches) in treating OLP or RAS by a revision of the literature.

Methods

According to PRISMA guidelines, the study assessed the remission of signs and symptoms in terms of decreasing burning sensation, pain severity, and lesion size. The protocol was registered on the PROSPERO database (CRD42024603173) and records identified by Medline/PubMed/Scopus.

Results

Thirteen observational studies involving humans affected by OLP or RAS were included. The absence of standardized therapies in terms of MDDS, drug, and dosing regimen was highlighted. All MDDS offered several benefits, including prolonged drug release, protection from mechanical irritation, and pain and inflammation reduction. MDDS improved patients' adherence by minimizing daily applications and systemic side effects.

Conclusions

MDDS may represent a promising option for both OLP and RAS treatments, addressing key limitations of traditional formulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsStomatitis, AphthousLichen Planus, OralHumansMouth Mucosa

Stichwörter der Autor:innen

buccal diseasebuccal tabletmucoadhesive filmmucoadhesive patchoral lichen planusrecurrent aphthous stomatitis

Autor:innen und Institutionen

  • Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche, Università degli Studi di Palermo, Palermo, Italy.
  • Dipartimento di Medicina di Precisione in Area Medica, Chirurgica e Critica (Me.Pre.C.C.), Università degli Studi di Palermo, Palermo, Italy.
  • Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali, Università degli Studi di Messina, Messina, Italy.
  • Unità di Medicina Orale e Odontoiatria per Pazienti Fragili, Dipartimento di Riabilitazione, Fragilità e Continuità delle Cure, Azienda Ospedaliera Universitaria di Palermo, Palermo, Italy.
  • Dipartimento di Biomedicina, Neuroscienze e Diagnostica avanzata (Bi.N.D.), Università degli Studi di Palermo, Palermo, Italy.

ORCID-Profile: M Coppini, V De Caro, G Di Prima, R Mauceri

Förderung

  • Ministero della Salute Project GENESIS-ATI, cod. T3-AN-11
  • Ministero dell'Università e della Ricerca and European Union-Next Generation EU, cod. PNRR M4.C2.1.1-2022CLLMCP_002

Zitieren

APA

Mauceri, M. E., Coppini, M., De Caro, V., Di Prima, G., Mauceri, R., Panzarella, V., Giuliana, G., & Campisi, G. (2026). Mucoadhesive Drug Delivery Systems for Oral Chronic Inflammatory Mucosal Diseases. The Future is Already Present. A Systematic Review. Oral Diseases, 32(1), 25-36. https://doi.org/10.1111/odi.70042

Vancouver

Mauceri ME, Coppini M, De Caro V, Di Prima G, Mauceri R, Panzarella V, et al. Mucoadhesive Drug Delivery Systems for Oral Chronic Inflammatory Mucosal Diseases. The Future is Already Present. A Systematic Review. Oral Diseases. 2026;32(1):25-36. doi:10.1111/odi.70042

BibTeX
@article{Mauceri2026,
  author = {Mauceri, M E and Coppini, M and De Caro, V and Di Prima, G and Mauceri, R and Panzarella, V and Giuliana, G and Campisi, G},
  title = {Mucoadhesive Drug Delivery Systems for Oral Chronic Inflammatory Mucosal Diseases. The Future is Already Present. A Systematic Review},
  journal = {Oral Diseases},
  year = {2026},
  volume = {32},
  number = {1},
  pages = {25--36},
  doi = {10.1111/odi.70042}
}
Kostenlos starten →